What is Catalent?

Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products. We have built an advanced range of technologies and capabilities and are dedicated to enabling a better and faster customer journey from product development to patient. With over 85 years of experience, Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. We became a publicly traded company (NYSE: CTLT) in 2014 and have grown to become a vibrant community of approximately 15,500 + employees who support over 7,000 products for over 1,000 customers all around the world. At Catalent, we share a common goal: to put patients first and help people around the world live better and healthier lives. (source)

Catalent Employee Count

Number of Catalent employees:

12,300 employees

Last updated 7/1/20

---

Catalent Revenue Totals

Catalent annual net revenue:

• FY 2021: $3.998 billion
• FY 2020: $3.094 billion
• FY 2019: $2.518 billion
• FY 2018: $2.463 billion
• FY 2017: $2.075 billion
• FY 2016: $1.848 billion
• FY 2015: $1.830 billion

---

Catalent annual net earnings:

• FY 2021: $585 million
• FY 2020: $221 million
• FY 2019: $137.4 million
• FY 2018: $83.6 million
• FY 2017: $109.8 million
• FY 2016: $111.2 million
• FY 2015: $201.3 million

---

Please note that some of these numbers are easier to find than others. A few of these Catalent statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.

Related Categories:

Related Tags: